When I first learned about CBD oil, I'll admit I was a bit skeptical. My mind immediately turned to weed and the unnerving experiences I'd had with heightened anxiety in college. For me, a person who's already predisposed to overthinking, marijuana, no matter what the form, would typically put my mind into overdrive and result in a common yet dreaded side effect: paranoia.
An actual long term study, Ganja in Jamaica: A Medical Anthropological Study of Chronic Marijuana Use, which was published in the Journal of the American Medical Association in 1975, showed zero concerns with addiction, even after patients who had used cannabis for decades had stopped. The 1980 study Cannabis in Costa Rica: A Study in Chronic Marijuana Use backed this up. Most interestingly, studies like this are not finding any addictive potential with CBD even in the presence of THC!
If you have dealt with anxiety before, you are not alone. As the author of a 2015 article published in the Dialogues in Clinical Neuroscience says: "Anxiety disorders...are the most prevalent mental disorders and are associated with immense health care costs and a high burden of disease." Yet many are finding that pharmaceuticals won't do, especially for chronic use, and they are turning increasingly to supplements and cannabidiol (CBD) oil for anxiety. 
With people across the globe mobilizing, putting their bodies on the line, and getting arrested en masse as part of a broad effort to force the political establishment to immediately pursue ambitious solutions to the climate crisis, new research published on Monday provided a grim look at what the future will bring if transformative change is not achieved: colossal flooding, bigger fires, stronger hurricanes and much more.
Linked to diet and lifestyle, atherosclerosis is common in developed Western nations and can lead to heart disease or stroke. It is a chronic inflammatory disorder involving the progressive depositing of atherosclerotic plaques (immune cells carrying oxidized LDL or low-density lipoproteins). A growing body of evidence suggests that endocannabinoid signaling plays a critical role in the pathology of atherogenesis. The condition is now understood to be a physical response to injuries in the arterial walls’ lining, caused by high blood pressure, infectious microbes, or excessive presence of an amino acid called homocysteine. Studies have demonstrated that inflammatory molecules stimulate the cycle leading to atherosclerotic lesions. Existing treatments are moderately effective though carry numerous side effects. CB2 receptors triple in response to inflammation, allowing anandamide and 2-AG, the body’s natural cannabinoids, to decrease inflammatory responses. The CB2 receptor is also stimulated by plant-based cannabinoids.
CBD also appears to counteract the sleep-inducing effects of THC. This is what makes CBD so appealing to the medical community, as the cause of psychoactive side effects has been a major barrier in the acceptance of medical marijuana. (20) While THC is known to cause anxiety and paranoia in some people, CBD works to counteract those side effects. For this reason, CBD benefits extend to being used in clinical trials on young children with epilepsy.
Enter CBD oil: an anti-inflammatory and anti-anxiety compound. I have seen in my own life, and many of my patients' lives, the positive impact CBD oil can have on anxiety. Studies have found that CBD oil is a natural anxiolytic (anxiety calmer) and is effective in treating social anxiety. CBD calms anxiety naturally without the potential side effects of pharmaceutical anti-anxiety medications.
As is the case with any plant that constitutes a crop, cannabis plants have been selectively bred over the years to bolster one or another desired characteristic. This means that some plants provide a more potent psychotropic effect, others possess more prominent seeds (used in the production of cooking oil traditionally), while others may make for sturdier textile fibers.
The 5-HT1A receptor (5-HT1AR) is an established anxiolytic target. Buspirone and other 5-HT1AR agonists are approved for the treatment of GAD, with fair response rates . In preclinical studies, 5-HT1AR agonists are anxiolytic in animal models of general anxiety , prevent the adverse effects of stress , and enhance fear extinction . Both pre- and postsynaptic 5-HT1ARs are coupled to various members of the Gi/o protein family. They are expressed on serotonergic neurons in the raphe, where they exert autoinhibitory function, and various other brain areas involved in fear and anxiety [54, 55]. Mechanisms underlying the anxiolytic effects of 5-HT1AR activation are complex, varying between both brain region, and pre- versus postsynaptic locus, and are not fully established . While in vitro studies suggest CBD acts as a direct 5-HT1AR agonist , in vivo studies are more consistent with CBD acting as an allosteric modulator, or facilitator of 5-HT1A signaling .
The 2014 Farm Bill, legalized the sale of "non-viable hemp material" grown within states participating in the Hemp Pilot Program. This legislation defined hemp as cannabis containing less than 0.3% of THC delta-9, grown within the regulatory framework of the Hemp Pilot Program. This has led many to insist that CBD manufactured from hemp, is legal in all 50 states and exempts its oversight by the DEA as a controlled substance. The 2018 Farm Bill is anticipated to provide further clarity regarding hemp regulations.
58. Rock EM, Bolognini D, Limebeer CL, et al. Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol. 2012;165:2620–2634. doi: 10.1111/j.1476-5381.2011.01621.x. [PMC free article] [PubMed] [CrossRef]
One of the few side effects of CBD oil is tiredness, but for many, it’s what they seek out in the natural herb. Since pharmaceuticals for aiding sleep pose risk for addiction and leave you feeling groggy the next day, it’s best to go the safe route with non-habit forming Cannabidiol. When searching for strains to combat insomnia, try staying with Indica and CBD-heavy strains to knock you out when you need it most.
I found your article to be very informative. My son has refractory Epilepsy and Type 1 Diabetes. I am very interested in CBD but I am concerned about how it will interact with the 3 AED’s he is currently taking as well as how it will affect his blood glucose levels as he is on an insulin pump. Do you know of anyone with a similar combination of issues? How they have handled introducing CBD to their regime? And if they are seeing positive results?
Reflecting the next morning, I was most surprised by the fact that I never felt "high" in any way—there was never a moment of It's kicking in; I can feel it now like with pain medications or even anti-anxiety drugs. Considering it takes time, consistency, and the right dosage to experience the full effect, I continued taking the oil once a day for the next six days. Here's what went down.
The studies done on CBD oil have a pretty wide dose range (anywhere from a few milligrams to hundreds of milligrams). I suggest starting at the lower end (around 10 milligrams) and slowly increasing over a few weeks or months to see what works for you. Some people also do well with splitting the dosage throughout the day instead of taking the dose all at once. As with everything, it is always a good idea to talk with your prescribing doctor if you are on any medications. CBD is generally very safe, but there are some pharmaceutical medications CBD oil could potentially interact with and increase or decrease the pharmaceutical drugs' effectiveness.